FR2792635B1 - Derives de cyclobutene-3,4-dione leur preparation et leur application en therapeutique - Google Patents

Derives de cyclobutene-3,4-dione leur preparation et leur application en therapeutique

Info

Publication number: FR2792635B1
Authority: FR; France
Prior art keywords: cyclobutene; preparation; therapeutic application; dione derivatives; dione
Prior art date: 1999-04-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

FR9904944A

Other languages

English (en)

Other versions

FR2792635A1 (fr

Inventor

Philippe R Bovy

Christophe Philippo

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Synthelabo SA

Original Assignee

Synthelabo SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-20

Filing date

1999-04-20

Publication date

2001-06-01

1999-04-20 Application filed by Synthelabo SA filed Critical Synthelabo SA

1999-04-20 Priority to FR9904944A priority Critical patent/FR2792635B1/fr

2000-04-11 Priority to AU39717/00A priority patent/AU3971700A/en

2000-04-11 Priority to PCT/FR2000/000925 priority patent/WO2000063170A1/fr

2000-04-18 Priority to CO00028561A priority patent/CO5170443A1/es

2000-04-18 Priority to ARP000101798A priority patent/AR023528A1/es

2000-04-19 Priority to UY26111A priority patent/UY26111A1/es

2000-10-27 Publication of FR2792635A1 publication Critical patent/FR2792635A1/fr

2001-06-01 Application granted granted Critical

2001-06-01 Publication of FR2792635B1 publication Critical patent/FR2792635B1/fr

2019-04-20 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Hematology (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Vascular Medicine (AREA)
Reproductive Health (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

FR9904944A 1999-04-20 1999-04-20 Derives de cyclobutene-3,4-dione leur preparation et leur application en therapeutique Expired - Fee Related FR2792635B1 (fr)

Priority Applications (6)

Application Number	Priority Date	Filing Date	Title
FR9904944A FR2792635B1 (fr)	1999-04-20	1999-04-20	Derives de cyclobutene-3,4-dione leur preparation et leur application en therapeutique
AU39717/00A AU3971700A (en)	1999-04-20	2000-04-11	Cyclobutene-3,4-dione derivatives as inhibitors of phosphodiesterase
PCT/FR2000/000925 WO2000063170A1 (fr)	1999-04-20	2000-04-11	Derives de cyclobutene-3,4-dione en tant qu'inhibiteurs de la phosphodiesterase 5
CO00028561A CO5170443A1 (es)	1999-04-20	2000-04-18	Derivados de coclobuten-3,4-diona,su preparacion y su aplicacion terapeutica.
ARP000101798A AR023528A1 (es)	1999-04-20	2000-04-18	Derivados de ciclobuten-3,4-diona, su preparacion y su aplicacion en terapeutica
UY26111A UY26111A1 (es)	1999-04-20	2000-04-19	Derivados de ciclobuten-3, 4-diona, su preparación y su aplicación en terapéutica

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9904944A FR2792635B1 (fr)	1999-04-20	1999-04-20	Derives de cyclobutene-3,4-dione leur preparation et leur application en therapeutique

Publications (2)

Publication Number	Publication Date
FR2792635A1 FR2792635A1 (fr)	2000-10-27
FR2792635B1 true FR2792635B1 (fr)	2001-06-01

Family

ID=9544619

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR9904944A Expired - Fee Related FR2792635B1 (fr)	1999-04-20	1999-04-20	Derives de cyclobutene-3,4-dione leur preparation et leur application en therapeutique

Country Status (6)

Country	Link
AR (1)	AR023528A1 (fr)
AU (1)	AU3971700A (fr)
CO (1)	CO5170443A1 (fr)
FR (1)	FR2792635B1 (fr)
UY (1)	UY26111A1 (fr)
WO (1)	WO2000063170A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6548490B1 (en) *	1997-10-28	2003-04-15	Vivus, Inc.	Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
US6403597B1 (en)	1997-10-28	2002-06-11	Vivus, Inc.	Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
DE10058663A1 (de) *	2000-11-25	2002-05-29	Merck Patent Gmbh	Verwendung von Thienopyrimidinen
US20040106794A1 (en) *	2001-04-16	2004-06-03	Schering Corporation	3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
AR068509A1 (es) *	2007-09-19	2009-11-18	Jerini Ag	Antagosnistas del receptor de bradiquinina b1

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9312210D0 (en) *	1993-06-14	1993-07-28	Smithkline Beecham Plc	Chemical compounds
AU722514B2 (en) *	1995-12-28	2000-08-03	Fujisawa Pharmaceutical Co., Ltd.	Benzimidazole derivatives

1999
- 1999-04-20 FR FR9904944A patent/FR2792635B1/fr not_active Expired - Fee Related
2000
- 2000-04-11 AU AU39717/00A patent/AU3971700A/en not_active Abandoned
- 2000-04-11 WO PCT/FR2000/000925 patent/WO2000063170A1/fr not_active Ceased
- 2000-04-18 CO CO00028561A patent/CO5170443A1/es not_active Application Discontinuation
- 2000-04-18 AR ARP000101798A patent/AR023528A1/es unknown
- 2000-04-19 UY UY26111A patent/UY26111A1/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2000063170A1 (fr)	2000-10-26
UY26111A1 (es)	2000-12-29
AU3971700A (en)	2000-11-02
CO5170443A1 (es)	2002-06-27
FR2792635A1 (fr)	2000-10-27
AR023528A1 (es)	2002-09-04

Similar Documents

Publication	Publication Date	Title
FR2791678B1 (fr)	2001-05-04	Derives de 1,4-diazabicyclo [3.2.2] nonane-4-carboxylates et -carboxamides, leur preparation et leur application en therapeutique
FR2790474B1 (fr)	2001-04-06	Derives de pyridopyranoazepines, leur preparation et leur application en therapeutique
MA27049A1 (fr)	2004-12-20	Derives de 1-phenylsulfonyl-1,3-dihydro-2h-indol-2-one, leur preparation et leur application en therapeutique
FR2786770B1 (fr)	2001-01-19	Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique
FR2786769B1 (fr)	2002-10-25	Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique
FR2843964B1 (fr)	2004-10-01	Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique
FR2786482B1 (fr)	2002-08-09	Nouveaux derives de 2-pyridone, leur preparation et leur application en therapeutique
MA27233A1 (fr)	2005-02-01	Derives de piperazinylacylpiperidine, leur preparation et leur application en therapeutique
FR2809730B1 (fr)	2002-07-19	Derives de 1,4-diazabicyclo[3.2.2] nonanebenzoxazole, -benzothiazole et -benzimidazole, leur preparation et leur application therapeutique
FR2850377B1 (fr)	2009-02-20	Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique
FR2809731B1 (fr)	2002-07-19	Derives de 1,4-diazabicyclo-[3.2.2] nonane-pheylisoxazole, leur preparation et leur application en therapeutique
FR2804430B1 (fr)	2002-03-22	Derives de 4-heteroaryl-1,4-diazabicyclo[3.2.2] nonane, leur preparation et leur application en therapeutique
FR2728900B1 (fr)	1997-01-31	Derives de 3-phenylisoquinolein-1(2h)-one, leur preparation et leur application en therapeutique
FR2766823B1 (fr)	1999-10-08	Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique
FR2845388B1 (fr)	2004-11-12	Derives de 1,4-diazabicyclo[3.2.2]nonanecarboxamides, leur preparation et leur application en therapeutique
FR2792318B1 (fr)	2001-06-15	Derives d'indazole, leur preparation et leur application en therapeutique
FR2771093B1 (fr)	2000-01-21	Derives d'imidazole, leur preparation et leur application en therapeutique
FR2788776B1 (fr)	2001-02-23	Derives de 4-oxo-3, 5-dihydro-4h-pyridazino [4,5-b] indole-1 -carboxamide, leur preparation et leur application en therapeutique
FR2761071B1 (fr)	1999-12-03	Derives de quinolein-2(1h)-one et de dihydroquinolein-2(1h)- one, leur preparation et leur application en therapeutique
FR2765874B1 (fr)	1999-08-13	Derives de 6-pyrrolidin-2-ylpyrindines, leur preparation et leur application en therapeutique
FR2792635B1 (fr)	2001-06-01	Derives de cyclobutene-3,4-dione leur preparation et leur application en therapeutique
FR2792634B1 (fr)	2001-06-01	Derives de 2-alcoxy-cyclobutene-3,4-dione leur preparation et leur application en therapeutique
FR2752839B1 (fr)	1998-10-09	Derives de benzofurane, leur preparation et leur application en therapeutique
FR2772378B1 (fr)	2000-02-04	Derives d'imidazole, leur preparation et leur application en therapeutique
FR2785903B1 (fr)	2002-10-25	Derives de 1-aminoethylquinoleine, leur preparation et leur application en therapeutique

Legal Events

Date	Code	Title	Description
2001-04-20	TP	Transmission of property
2003-02-07	ST	Notification of lapse